SCHEMBL29440106

SCHEMBL29440106

COC(=O)C1C(=O)C2CCC2N1C(=O)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
AGTR2 P50052 4/20 0.44
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44
PSENEN Q9NZ42 1/20 0.44
HTT P42858 2/20 0.43
MITF O75030 1/20 0.43
MAPT P10636 1/20 0.43
PDE4B Q07343 1/20 0.43
CPB1 P15086 1/20 0.42
CYP2C19 P33261 1/20 0.42
FKBP1A P62942 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29440077 1.00 HTR2C (0.51) HTR2CSMN1; SMN2NPC1RAB9AAGTR2
SCHEMBL26009502 0.83 HTR2C (0.59) HTR2CSMN1; SMN2NPC1RAB9AAGTR2
SCHEMBL1012764 0.83 HTR2C (0.52) HTR2CSMN1; SMN2NPC1RAB9AAGTR2
SCHEMBL9546447 0.77 HTR2C (0.57) HTR2CSMN1; SMN2NPC1RAB9AAGTR2
SCHEMBL26010039 0.77 HTR2C (0.44) HTR2CSMN1; SMN2NPC1RAB9AHTT
SCHEMBL29440145 0.77 HTR2C (0.57) HTR2CSMN1; SMN2NPC1RAB9APSEN1
SCHEMBL30800897 0.77 HTR2C (0.57) HTR2CSMN1; SMN2NPC1RAB9APSEN1
SCHEMBL25635682 0.77 HTR2C (0.57) HTR2CSMN1; SMN2NPC1RAB9APSEN1
SCHEMBL29012379 0.77 HTR2C (0.57) HTR2CSMN1; SMN2NPC1RAB9APSEN1
SCHEMBL29440040 0.77 HTR2C (0.48) HTR2CSMN1; SMN2NPC1RAB9AAGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4199925-A1 CYCLOPENTAPYRROLE OREXIN RECEPTOR AGONISTS Merck Sharp & Dohme LLC (US) 2023-06-28 EP disclosed
WO-2022040058-A1 CYCLOPENTAPYRROLE OREXIN RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2022-02-24 WO disclosed